PortfoliosLab logo
PortfoliosLab logo
Tools
Portfolios
Screeners
Discussions
CSTL vs. FCX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between CSTL and FCX is 0.34, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

CSTL vs. FCX

Last updated May 31, 2025

Compare and contrast key facts about Castle Biosciences, Inc. (CSTL) and Freeport-McMoRan Inc. (FCX).

Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: CSTL or FCX.

Performance

CSTL vs. FCX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Castle Biosciences, Inc. (CSTL) and Freeport-McMoRan Inc. (FCX). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

CSTL:

-0.58

FCX:

-0.57

Sortino Ratio

CSTL:

-0.60

FCX:

-0.69

Omega Ratio

CSTL:

0.92

FCX:

0.91

Calmar Ratio

CSTL:

-0.42

FCX:

-0.59

Martin Ratio

CSTL:

-1.34

FCX:

-1.26

Ulcer Index

CSTL:

25.98%

FCX:

21.62%

Daily Std Dev

CSTL:

58.56%

FCX:

44.48%

Max Drawdown

CSTL:

-88.02%

FCX:

-92.44%

Current Drawdown

CSTL:

-83.59%

FCX:

-28.86%

Fundamentals

Market Cap

CSTL:

$468.60M

FCX:

$56.05B

EPS

CSTL:

-$0.19

FCX:

$1.22

PS Ratio

CSTL:

1.35

FCX:

2.25

PB Ratio

CSTL:

1.05

FCX:

3.16

Total Revenue (TTM)

CSTL:

$347.08M

FCX:

$24.86B

Gross Profit (TTM)

CSTL:

$298.06M

FCX:

$7.17B

EBITDA (TTM)

CSTL:

$37.27M

FCX:

$8.94B

Returns By Period

In the year-to-date period, CSTL achieves a -40.08% return, which is significantly lower than FCX's 1.89% return.

CSTL

YTD

-40.08%

1M

-20.35%

6M

-47.26%

1Y

-34.04%

3Y*

-10.49%

5Y*

-16.11%

10Y*

N/A

FCX

YTD

1.89%

1M

6.80%

6M

-12.22%

1Y

-25.39%

3Y*

1.04%

5Y*

35.11%

10Y*

7.63%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Castle Biosciences, Inc.

Freeport-McMoRan Inc.

Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

CSTL vs. FCX — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
CSTL
The Risk-Adjusted Performance Rank of CSTL is 1818
Overall Rank
The Sharpe Ratio Rank of CSTL is 1818
Sharpe Ratio Rank
The Sortino Ratio Rank of CSTL is 1919
Sortino Ratio Rank
The Omega Ratio Rank of CSTL is 2020
Omega Ratio Rank
The Calmar Ratio Rank of CSTL is 2424
Calmar Ratio Rank
The Martin Ratio Rank of CSTL is 1010
Martin Ratio Rank
FCX
The Risk-Adjusted Performance Rank of FCX is 1616
Overall Rank
The Sharpe Ratio Rank of FCX is 1818
Sharpe Ratio Rank
The Sortino Ratio Rank of FCX is 1818
Sortino Ratio Rank
The Omega Ratio Rank of FCX is 1818
Omega Ratio Rank
The Calmar Ratio Rank of FCX is 1414
Calmar Ratio Rank
The Martin Ratio Rank of FCX is 1414
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

CSTL vs. FCX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Castle Biosciences, Inc. (CSTL) and Freeport-McMoRan Inc. (FCX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current CSTL Sharpe Ratio is -0.58, which is comparable to the FCX Sharpe Ratio of -0.57. The chart below compares the historical Sharpe Ratios of CSTL and FCX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

CSTL vs. FCX - Dividend Comparison

CSTL has not paid dividends to shareholders, while FCX's dividend yield for the trailing twelve months is around 1.56%.

TTM20242023202220212020201920182017201620152014
CSTL
Castle Biosciences, Inc.		0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
FCX
Freeport-McMoRan Inc.		1.56%1.58%1.41%1.58%0.54%0.19%1.52%1.45%0.00%0.00%8.48%5.36%

Drawdowns

CSTL vs. FCX - Drawdown Comparison

The maximum CSTL drawdown since its inception was -88.02%, roughly equal to the maximum FCX drawdown of -92.44%. Use the drawdown chart below to compare losses from any high point for CSTL and FCX.

Loading data...

Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

CSTL vs. FCX - Volatility Comparison

Castle Biosciences, Inc. (CSTL) has a higher volatility of 14.93% compared to Freeport-McMoRan Inc. (FCX) at 8.17%. This indicates that CSTL's price experiences larger fluctuations and is considered to be riskier than FCX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Loading data...

Financials

CSTL vs. FCX - Financials Comparison

This section allows you to compare key financial metrics between Castle Biosciences, Inc. and Freeport-McMoRan Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.

Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities

0.001.00B2.00B3.00B4.00B5.00B6.00B7.00B20212022202320242025
87.99M
5.73B
(CSTL) Total Revenue
(FCX) Total Revenue
Values in USD except per share items

CSTL vs. FCX - Profitability Comparison

The chart below illustrates the profitability comparison between Castle Biosciences, Inc. and Freeport-McMoRan Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.
Gross Margin
Operating Margin
Net Margin
Quarterly
Annual
-20.0%0.0%20.0%40.0%60.0%80.0%100.0%20212022202320242025
100.0%
25.6%
(CSTL) Gross Margin
(FCX) Gross Margin
CSTL - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Castle Biosciences, Inc. reported a gross profit of 87.99M and revenue of 87.99M. Therefore, the gross margin over that period was 100.0%.

FCX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Freeport-McMoRan Inc. reported a gross profit of 1.47B and revenue of 5.73B. Therefore, the gross margin over that period was 25.6%.

CSTL - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Castle Biosciences, Inc. reported an operating income of -27.93M and revenue of 87.99M, resulting in an operating margin of -31.7%.

FCX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Freeport-McMoRan Inc. reported an operating income of 1.30B and revenue of 5.73B, resulting in an operating margin of 22.8%.

CSTL - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Castle Biosciences, Inc. reported a net income of -25.85M and revenue of 87.99M, resulting in a net margin of -29.4%.

FCX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Freeport-McMoRan Inc. reported a net income of 352.00M and revenue of 5.73B, resulting in a net margin of 6.2%.